| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/SIM.1566 |
| P698 | PubMed publication ID | 12973783 |
| P2093 | author name string | Ades AE | |
| P2860 | cites work | Bayesian measures of model complexity and fit | Q56532420 |
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2995-3016 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Statistics in Medicine | Q7604438 |
| P1476 | title | A chain of evidence with mixed comparisons: models for multi-parameter synthesis and consistency of evidence | |
| P478 | volume | 22 |
| Q33261643 | 'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data |
| Q39836056 | A multipoint method for meta-analysis of genetic association studies |
| Q33830562 | A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer |
| Q38819936 | A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation |
| Q35553233 | An assessment of the methodological quality of published network meta-analyses: a systematic review |
| Q93136489 | An indirect treatment comparison of the efficacy of pembrolizumab versus competing regimens for the adjuvant treatment of stage III melanoma |
| Q46701262 | Assessing the cost-effectiveness of new pharmaceuticals in epilepsy in adults: the results of a probabilistic decision model. |
| Q58602389 | Automated methods to Test Connectedness and Quantify Indirectness of Evidence in Network Meta-Analysis |
| Q44317372 | Bayesian indirect and mixed treatment comparisons across longitudinal time points |
| Q36381197 | Bayesian methods for evidence synthesis in cost-effectiveness analysis |
| Q35926501 | Beyond classical meta-analysis: can inadequately reported studies be included? |
| Q38512940 | Combining randomized and non-randomized evidence in clinical research: a review of methods and applications |
| Q64904022 | Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis. |
| Q37163118 | Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling |
| Q38093098 | Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials |
| Q36842051 | Economic evaluation and catheter-related bloodstream infections |
| Q31017619 | Estimation of markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis, and model calibration |
| Q50789678 | Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis. |
| Q33437253 | Evidence synthesis as the key to more coherent and efficient research |
| Q41822229 | Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials |
| Q36991723 | Evidence synthesis for decision making 5: the baseline natural history model |
| Q36359124 | Evidence synthesis, parameter correlation and probabilistic sensitivity analysis |
| Q30251972 | GetReal in network meta-analysis: a review of the methodology |
| Q37384150 | Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison |
| Q40028428 | Multiparameter evidence synthesis in epidemiology and medical decision-making |
| Q36394490 | Multiple treatment comparisons in a series of anti-malarial trials with an ordinal primary outcome and repeated treatment evaluations |
| Q36537410 | Multivariate meta-analysis for non-linear and other multi-parameter associations |
| Q30969336 | Network meta-analysis of individual and aggregate level data |
| Q35602850 | Network meta-analysis of longitudinal data using fractional polynomials |
| Q33600403 | Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial |
| Q33943750 | Network meta-analysis-highly attractive but more methodological research is needed |
| Q39366897 | Presentational approaches used in the UK for reporting evidence synthesis using indirect and mixed treatment comparisons. |
| Q37403972 | Randomized studies are needed to assess the true role of self-monitoring of blood glucose in noninsulin-treated type 2 diabetes |
| Q93489203 | Reply: SUN BEVIFN in first-line mRCC therapy: no evidence for a statistically significant difference in progression-free survival |
| Q28291828 | Secondary prophylaxis of variceal bleeding for cirrhotic patients: a multiple-treatments meta-analysis |
| Q92076419 | Shared parameter model for competing risks and different data summaries in meta-analysis: Implications for common and rare outcomes |
| Q37287465 | Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness |
| Q26996629 | Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma |
| Q39562509 | The choice of a noninformative prior on between-study variance strongly affects predictions of future treatment effect |
| Q55513961 | The use of single armed observational data to closing the gap in otherwise disconnected evidence networks: a network meta-analysis in multiple myeloma. |
| Q30249635 | What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis. |
| Q40349299 | Whither trial-based economic evaluation for health care decision making? |
Search more.